AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that the Company has significantly expanded distribution of its revolutionary skincare products via additional sales channels in Japan.
| IRVINE, Calif., April 22, 2019 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that the Company has significantly expanded distribution of its revolutionary skincare products via additional sales channels in Japan. The expanded distribution will place the ROOT of SKIN™ product line on the shelves of 9300 beauty and lash salons, and within a Japanese online platform that currently sells cosmetics to 1.4M online buyers. Execution of these distribution deals follows a string of successful appearances on the home shopping channel QVC Japan, in which the products set consecutive sales records for consistent sell outs in as little as the first 10 minutes of the hour-long shows.
ROOT of SKIN™ is AIVITA’s proprietary consumer skincare line for skin rejuvenation, made possible through the same proprietary knowledge and expertise used to develop its cutting-edge cell therapies. The all-new actives complex SourceCode Technology™ contains the complete set of factors and supporting biological components present in young, healthy skin. AIVITA uses 100% of proceeds from the sale of its ROOT of SKIN™ skincare line to support the treatment of women with ovarian cancer. “ROOT of SKIN™ is a truly disruptive technology with a mission that has never before existed in the aesthetics sector,” said Dr. Hans Keirstead, AIVITA’s Chief Executive Officer. “These new distribution channels, in such a premier market, enable revenue projections that ensure our mission will be realized.” Last month, AIVITA executed a partnership with the global multichannel marketing company Guthy-Renker to promote the products worldwide. About ROOT of SKIN™ ROOT of SKIN™ is a rejuvenating line of skincare products fueled by an unrelenting pursuit for advancements in life-changing and life-saving treatments. Harnessing breakthroughs in stem cell therapy, AIVITA Biomedical developed a technology that does more than just boost regeneration. The patented actives complex SourceCode Technology™ renews, repairs and protects, just as your skin did at its youngest and healthiest stage. Rich with every biological component healthy skin needs for development, and free of any unnecessary ingredients. All proceeds support the treatment of women with ovarian cancer. About AIVITA Biomedical AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline and commercial line of skin care products.
SOURCE AIVITA Biomedical, Inc. |
View original content to download multimedia:
